PHILADELPHIA, March 5, 2019 /PRNewswire/ -- Carisma Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies based on chimeric antigen receptor macrophages, today announced that the Company's management will present at three upcoming investor and industry conferences:
- William Blair 9th Annual Cancer Immunotherapy Conference – Carisma's management will deliver a scientific presentation on March 20, 2019 at 9:55 am EST. The conference will be held at the Apella, Event Space Alexandria Center in New York, NY;
- Alliance for Regenerative Medicine Cell & Gene Investment Day – Carisma's management will participate in the conference in New York City and provide a corporate update on March 21, 2019, at 2:15 p.m. EST; and
- Keystone Symposia on Molecular and Cellular Biology: Innate and Non-Classical Immune Cells in Cancer Immunotherapy – Carisma's management will present in the Cellular Therapies and Biomarkers session on March 28, 2019 at 2:30 p.m. MST. The conference will be held at the Keystone Resort, Keystone, CO.
The Alliance for Regenerative Medicine Cell & Gene Investment Day is filmed and livestreamed from the meeting website at http://arminvestorday.com/webcast/.
About Carisma Therapeutics Inc.
Carisma Therapeutics Inc. is biopharmaceutical company bringing the power of adoptive cellular immunotherapy to solid tumor patients through a differentiated platform using chimeric antigen receptor macrophages. Carisma Therapeutics is headquartered in Philadelphia, PA. For more information, please see the Company's website at https://carismatx.com/.
Deirdre Purdy for Carisma Therapeutics
SOURCE Carisma Therapeutics Inc.